BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32249532)

  • 1. Structure-Activity Relationship of Phenylpyrazolones against Trypanosoma cruzi.
    Sijm M; Sterk GJ; Caljon G; Maes L; de Esch IJP; Leurs R
    ChemMedChem; 2020 Jul; 15(14):1310-1321. PubMed ID: 32249532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Phenylpyrazolone Dimers as a New Class of Anti-Trypanosoma cruzi Agents.
    Sijm M; Siciliano de Araújo J; Ramos Llorca A; Orrling K; Stiny L; Matheeussen A; Maes L; de Esch IJP; de Nazaré Correia Soeiro M; Sterk GJ; Leurs R
    ChemMedChem; 2019 Sep; 14(18):1662-1668. PubMed ID: 31319019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure Activity Relationship of
    Sijm M; Maes L; de Esch IJP; Caljon G; Sterk GJ; Leurs R
    Front Chem; 2021; 9():608438. PubMed ID: 33996737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 4-((1-(1H-imidazol-2-yl)alkoxy)methyl)pyridines as a new class of Trypanosoma cruzi growth inhibitors.
    Ponzi S; Bresciani A; Kaiser M; Nardi V; Nizi E; Ontoria JM; Pace P; Paonessa G; Summa V; Harper S
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127052. PubMed ID: 32113841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation.
    Cardoso MV; de Siqueira LR; da Silva EB; Costa LB; Hernandes MZ; Rabello MM; Ferreira RS; da Cruz LF; Moreira DR; Pereira VR; de Castro MC; Bernhardt PV; Leite AC
    Eur J Med Chem; 2014 Oct; 86():48-59. PubMed ID: 25147146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of pyridyl-pyrazolone derivatives against Trypanosoma cruzi.
    Batista DDGJ; de Almeida Fiuza LF; Klupsch F; da Costa KN; Batista MM; da Conceição K; Bouafia H; Vergoten G; Millet R; Thuru X; Bailly C; Soeiro MNC
    Exp Parasitol; 2024 Jul; 262():108787. PubMed ID: 38759776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Novel Pyrazolone Phosphodiesterase Inhibitors in Experimental Mouse Models of Trypanosoma cruzi.
    de Araújo JS; França da Silva C; Batista DDGJ; Nefertiti A; Fiuza LFA; Fonseca-Berzal CR; Bernardino da Silva P; Batista MM; Sijm M; Kalejaiye TD; de Koning HP; Maes L; Sterk GJ; Leurs R; Soeiro MNC
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
    Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
    Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanocidal activity of 5,6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi.
    de Fátima A; Marquissolo C; de Albuquerque S; Carraro-Abrahão AA; Pilli RA
    Eur J Med Chem; 2006 Oct; 41(10):1210-3. PubMed ID: 16815596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
    da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
    Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Parasiticidal Activities of Phthalimides: Synthesis and Biological Profile against Trypanosoma cruzi and Plasmodium falciparum.
    Teixeira de Moraes Gomes PA; Veríssimo de Oliveira Cardoso M; Dos Santos IR; Amaro de Sousa F; da Conceição JM; Gouveia de Melo Silva V; Duarte D; Pereira R; Oliveira R; Nogueira F; Alves LC; Brayner FA; da Silva Santos AC; Rêgo Alves Pereira V; Lima Leite AC
    ChemMedChem; 2020 Nov; 15(22):2164-2175. PubMed ID: 32813331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural-product-inspired design and synthesis of two series of compounds active against Trypanosoma cruzi: Insights into structure-activity relationship, toxicity, and mechanism of action.
    da Rosa R; Dambrós BP; Höehr de Moraes M; Grand L; Jacolot M; Popowycz F; Steindel M; Schenkel EP; Campos Bernardes LS
    Bioorg Chem; 2022 Feb; 119():105492. PubMed ID: 34838333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New benzimidazolequinones as trypanosomicidal agents.
    López-Lira C; Tapia RA; Herrera A; Lapier M; Maya JD; Soto-Delgado J; Oliver AG; Graham Lappin A; Uriarte E
    Bioorg Chem; 2021 Jun; 111():104823. PubMed ID: 33798844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug.
    Vega MC; Rolón M; Montero-Torres A; Fonseca-Berzal C; Escario JA; Gómez-Barrio A; Gálvez J; Marrero-Ponce Y; Arán VJ
    Eur J Med Chem; 2012 Dec; 58():214-27. PubMed ID: 23124218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.
    Soares FGN; Göethel G; Kagami LP; das Neves GM; Sauer E; Birriel E; Varela J; Gonçalves IL; Von Poser G; González M; Kawano DF; Paula FR; de Melo EB; Garcia SC; Cerecetto H; Eifler-Lima VL
    BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):76. PubMed ID: 31852548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydrodieugenol B derivatives as antiparasitic agents: Synthesis and biological activity against Trypanosoma cruzi.
    Ferreira DD; Sousa FS; Costa-Silva TA; Reimão JQ; Torrecilhas AC; Johns DM; Sear CE; Honorio KM; Lago JHG; Anderson EA; Tempone AG
    Eur J Med Chem; 2019 Aug; 176():162-174. PubMed ID: 31103897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-(phenylthio)ethylidene derivatives as anti-Trypanosoma cruzi compounds: Structural design, synthesis and antiparasitic activity.
    Cardoso MVO; Oliveira Filho GB; Siqueira LRP; Espíndola JWP; Silva EBD; Mendes APO; Pereira VRA; Castro MCAB; Ferreira RS; Villela FS; Costa FMRD; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2019 Oct; 180():191-203. PubMed ID: 31306906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New oxirane derivatives of 1,4-naphthoquinones and their evaluation against T. cruzi epimastigote forms.
    Carneiro PF; do Nascimento SB; Pinto AV; Pinto Mdo C; Lechuga GC; Santos DO; dos Santos Júnior HM; Resende JA; Bourguignon SC; Ferreira VF
    Bioorg Med Chem; 2012 Aug; 20(16):4995-5000. PubMed ID: 22795899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Methyl-7-Aryl-7-Deazapurine Nucleosides as Anti-Trypanosoma cruzi Agents: Structure-Activity Relationship and in vivo Efficacy.
    Lin C; Ferreira de Almeida Fiuza L; Cardoso Santos C; Ferreira Nunes D; Cruz Moreira O; Bouton J; Karalic I; Maes L; Caljon G; Hulpia F; de Nazaré C Soeiro M; Van Calenbergh S
    ChemMedChem; 2021 Jul; 16(14):2231-2253. PubMed ID: 33856742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.